endometrial intraepithelial neoplasia ein premalignant lesion uterine lining predisposes endometrioid endometrial adenocarcinoma composed collection abnormal endometrial cells arising glands line uterus tendency time progress common form uterine adenocarcinoma endometrioid type ein lesions discovered combination molecular histologic clinical outcome studies beginning provide multifaceted characterization disease subset larger mixed group lesions previously called endometrial ein diagnostic schema intended replace previous endometrial hyperplasia classification defined world health organization separated benign benign endometrial hyperplasia premalignant ein classes accordance behavior clinical management ein confused unrelated entity serous intraepithelial carcinoma serous eic early stage different tumor type known papillary serous adenocarcinoma also occurs location within uterus average age time ein diagnosis approximately years compared approximately years carcinoma timeframe likelihood ein progression cancer however constant amongst women cases ein first detected residual premalignant disease women already carcinoma whereas ein lesions disappear entirely never lead cancer reason treatment benefits risks must individualized patient guidance experienced physician risk factors development ein endometrioid type endometrial carcinoma include exposure estrogens without opposing progestins obesity diabetes rare hereditary conditions hereditary nonpolyposis colorectal cancer protective factors include use combined oral contraceptive pills low dose estrogen progestin prior use contraceptive intrauterine device ein lesions demonstrate behaviors characteristics premalignant precancerous lesion precancer features ein table cells ein lesion genetically different normal malignant tissues distinctive appearance light microscope ein cells already neoplastic demonstrating monoclonal growth pattern clonally distributed mutations progression ein carcinoma effectively conversion benign neoplasm malignant neoplasm accomplished acquisition additional mutations accompanied change behavior characterized ability invade local tissues metastasize regional distant sites table precancer characteristics ein ein biomarkers figure single biomarkers completely informative recognition ein tumour suppressor gene pten frequently inactivated ein abnormally turned approximately ein lesions seen special tissue stains applied histological sections known pten immunohistochemistry brown pten protein seen absent crowded tubular glands make ein lesion diagnosis ein lesions clinical importance increased risk coexisting women ein diagnosed carcinoma within one year future long term endometrial cancer risk times greater woman ein compared one benign endometrial histology endometrial cancer diagnostic terminology used pathologists physicians diagnose human disease examination histologic preparations excised tissues critical distinctions ein diagnosis separation benign conditions benign endometrial hyperplasia field effect endometrial tissue caused excessive stimulation hormone estrogen cancer spectrum disease must distinguished ein table ii includes benign endometrial hyperplasia table ii disease classes need distinguished ein ein may diagnosed trained pathologist examination tissue sections endometrium following diagnostic criteria must met single area one tissue fragment make diagnosis table iii table iii ein diagnosis pten gene httpsenwikipediaorgwikiendometrialintraepithelialneoplasia